Kwality Pharmaceuticals Limited (BOM:539997)
3,590.75
+146.00 (4.24%)
At close: Aug 17, 2026
Kwality Pharmaceuticals Revenue
Kwality Pharmaceuticals had revenue of 1.62B INR in the quarter ending June 30, 2026, with 45.63% growth. This brings the company's revenue in the last twelve months to 5.54B, up 37.94% year-over-year. In the fiscal year ending March 31, 2026, Kwality Pharmaceuticals had annual revenue of 5.03B with 35.90% growth.
Revenue (ttm)
5.54B
Revenue Growth
+37.94%
P/S Ratio
6.73
Revenue / Employee
4.87M
Employees
1,137
Market Cap
37.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.03B | 1.33B | 35.90% |
| Mar 31, 2025 | 3.70B | 630.25M | 20.52% |
| Mar 31, 2024 | 3.07B | 561.42M | 22.36% |
| Mar 31, 2023 | 2.51B | -2.05B | -44.97% |
| Mar 31, 2022 | 4.56B | 1.93B | 73.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 23.17B |
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |
| Hikal | 17.35B |
| Bliss GVS Pharma | 10.05B |
| Gufic Biosciences | 9.81B |
| Venus Remedies | 8.11B |
Kwality Pharmaceuticals News
- 7 days ago - Kwality Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 7 days ago - Kwality Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 7 days ago - Kwality Pharmaceuticals Slides: Q1 2027 - Filings
- 3 months ago - Kwality Pharmaceuticals Quarterly report: Q4 2026 - Filings
- 3 months ago - Kwality Pharmaceuticals Annual report: Q4 2026 - Filings
- 6 months ago - Kwality Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 6 months ago - Kwality Pharmaceuticals Slides: Q3 2026 - Filings
- 9 months ago - Kwality Pharmaceuticals Quarterly report: Q2 2026 - Filings